Tuesday, August 11

Browsing: MedPal

MedPal set to benefit from approval of second oral weight

By healthylife7August 11, 20260

MedPal AI (MPAL ), the AI-native digital health and pharmacy group, has highlighted that the UK has become the first country in Europe to authorise orforglipron (brand name Foundayo), Eli Lilly’s once daily oral GLP-1 tablet

Wellness Tips

MedPal highlights new UK oral weight

By healthylife7August 11, 20260

MedPal AI plc (AIM: MPAL)has highlighted the UK approval of Eli Lilly’s once-daily oral GLP-1 treatment, Foundayo, which has been authorised for weight loss and weight maintenance in eligible adults

Wellness Tips

Eli Lilly and Company (LLY) vs. Novo Nordisk A/S (NVO): Is Lilly Pulling Ahead in the $100 Billion Obesity Market?

By healthylife7August 11, 20260

The duopoly dominating the multi-billion-dollar GLP-1 weight-loss market has moved from pharmacy shelves to the federal courtroom. Novo Nordisk A/S (NYSE:NVO) filed a lawsuit in U.S. District Court in New Jersey against Eli Lilly and Company (NYSE:LLY) on July 21, accusing its primary rival of false advertising and unfair competition regarding television and digital campaigns…

What's Hot

Eli Lilly and Company (LLY) vs. Novo Nordisk A/S (NVO): Is Lilly Pulling Ahead in the $100 Billion Obesity Market?

Frida Launches Personal Care for Kids, Bringing Its Problem-Solving Innovation to an Overlooked Stage of Growing Up

Readers respond: Count disease in dangerous occupations

Browsing: MedPal

MedPal set to benefit from approval of second oral weight

MedPal highlights new UK oral weight

Eli Lilly and Company (LLY) vs. Novo Nordisk A/S (NVO): Is Lilly Pulling Ahead in the $100 Billion Obesity Market?

Frida Launches Personal Care for Kids, Bringing Its Problem-Solving Innovation to an Overlooked Stage of Growing Up

Readers respond: Count disease in dangerous occupations

Hims & Hers shares slide as costly weight

Opinion: The FDA must put biotech at its center or continue to cede early research to China

Inside Elevance’s digital chronic disease management strategy

Best, Worst States For Well

What do the Middle Ages tell us about mental health then and now? VCU historian Leigh Ann Craig has answers

Fitness

Eli Lilly and Company (LLY) vs. Novo Nordisk A/S (NVO): Is Lilly Pulling Ahead in the $100 Billion Obesity Market?

Frida Launches Personal Care for Kids, Bringing Its Problem-Solving Innovation to an Overlooked Stage of Growing Up

Readers respond: Count disease in dangerous occupations

Health

Opinion: The FDA must put biotech at its center or continue to cede early research to China

Inside Elevance’s digital chronic disease management strategy

Best, Worst States For Well

Subscribe to Updates

What's Hot

Browsing: MedPal